Kura Oncology Inc. logo

Kura Oncology Inc. (KURA)

Market Closed
20 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
10. 68
-0.18
-1.6575%
$
997.82M Market Cap
- P/E Ratio
- Div Yield
799,313 Volume
-2.32 Eps
$ 10.86
Previous Close
Add Transaction
Day Range
10.67 11.16
Year Range
5.45 12.49
Want to track KURA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kura Oncology, Inc. (KURA) Q3 2024 Earnings Call Transcript

Kura Oncology, Inc. (KURA) Q3 2024 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Pete De Spain - Head, Investor Relations Dr. Troy Wilson - President and CEO Tom Doyle - Senior Vice President, Finance and Accounting Dr. Mollie Leoni - Executive Vice President, Clinical Development Conference Call Participants Li Watsek - Cantor Jonathan Chang - Leerink Partners Jason Zemansky - Bank of America Roger Song - Jefferies Charles Zhu - LifeSci Capital Phil Nadeau - TD Cowen Peter Lawson - Barclays Justin Zelin - BTIG Brad Canino - Stifel Operator Good afternoon, ladies and gentlemen. Welcome to the Kura Oncology Third Quarter 2024 Financial Results Call.

Seekingalpha | 1 year ago
Kura Oncology, Inc. (KURA) Q2 2024 Earnings Call Transcript

Kura Oncology, Inc. (KURA) Q2 2024 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Pete De Spain - Head, IR Troy Wilson - President and CEO Thomas Doyle - SVP of Finance and Accounting Conference Call Participants Li Watsek - Cantor Fitzgerald Jonathan Chang - Leerink Partners Cameron Bozdog - Bank of America Roger Song - Jefferies Brad Canino - Stifel Phil Nadeau - TD Cowen Alex Bouilloux - Barclays Justin Zelin - BTIG George Farmer - Scotiabank Operator Good day, and welcome to the Q2 2024 Kura Oncology Conference Call. [Operator Instructions] Please note this event is being recorded.

Seekingalpha | 1 year ago